Search This Blog

Wednesday, December 18, 2019

89bio reports Q3 results

89bio (NASDAQ:ETNB): Q3 GAAP EPS of -$30.63.
Cash, cash equivalents and marketable securities $113.8M including gross proceeds from its IPO.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)